Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant‐induced arthritis
Open Access
- 23 September 2013
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 17 (12), 1577-1587
- https://doi.org/10.1111/jcmm.12128
Abstract
The angiotensin II type 1 receptor (AT1R) blocker losartan ameliorates rheumatoid arthritis (RA) in an experimental model. In RA, AT2R mainly opposes AT1R, but the mechanism by which this occurs still remains obscure. In the present study, we investigated the role of AT2R in the treatment of rats with adjuvant-induced arthritis (AIA) by losartan. Adjuvant-induced arthritis rats were treated with losartan (5, 10 and 15 mg/kg) and methotrexate (MTX; 0.5 mg/kg) in vivo from day 14 to day 28. Arthritis was evaluated by the arthritis index and histological examination. Angiotensin II, tumour necrosis factor-α, and VEGF levels were examined by ELISA. The expression of AT1R and AT2R was detected by western blot and immunohistochemistry analysis. After stimulation with interleukin-1β in vitro, the effects of the AT2R agonist CGP42112 (10−8–10−5 M) on the chemotaxis of monocytes induced by 10% foetal calf serum (FCS) were analysed by using Transwell assay. Subsequently, the therapeutic effects of CGP42112 (5, 10 and 20 μg/kg) were evaluated in vivo by intra-articular injection in AIA rats. After treatment with losartan, the down-regulation of AT1R expression and up-regulation of AT2R expression in the spleen and synovium of AIA rats correlated positively with reduction in the polyarthritis index. Treatment with CGP42112 inhibited the chemotaxis of AIA monocytes in vitro, possibly because of the up-regulation of AT2R expression. Intra-articular injection with CGP42112 (10 and 20 μg/kg) ameliorated the arthritis index and histological signs of arthritis. In summary, the present study strongly suggests that the up-regulation of AT2R might be an additional mechanism by which losartan exerts its therapeutic effects in AIA rats.Keywords
This publication has 36 references indexed in Scilit:
- Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in ratsEuropean Journal of Pharmacology, 2012
- Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritisActa Pharmacologica Sinica, 2010
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2008
- Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitisArthritis & Rheumatism, 2007
- Differential expression of angiotensin receptors in human cutaneous wound healingBritish Journal of Dermatology, 2005
- Angiotensin receptor blockers suppress antigen‐specific T cell responses and ameliorate collagen‐induced arthritis in miceArthritis & Rheumatism, 2005
- Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritisRheumatology International, 2005
- Angiotensin converting enzyme in human synovium: increased stromal [125I]351A binding in rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2000
- Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition.Annals Of The Rheumatic Diseases, 1990